Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $14,887,810.00
- $1,037,179,923.19
- March 13, 2026
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| July 1, 2015 | Director | 11,700 | $125.60 | Sell | $1,469,520.00 | |
| June 24, 2015 | Director | 11,700 | $130.41 | Sell | $1,525,797.00 | |
| June 17, 2015 | Director | 11,700 | $123.90 | Sell | $1,449,630.00 | |
| June 10, 2015 | Director | 11,700 | $125.02 | Sell | $1,462,734.00 | |
| May 20, 2015 | Director | 11,700 | $126.73 | Sell | $1,482,741.00 | |
| May 6, 2015 | Director | 11,700 | $122.79 | Sell | $1,436,643.00 | |
| May 5, 2015 | SVP | 4,101 | $123.68 | Sell | $507,211.68 | |
| April 29, 2015 | Director | 11,700 | $124.59 | Sell | $1,457,703.00 | |
| April 27, 2015 | EVP | 61,480 | $129.36 | Sell | $7,953,052.80 | |
| April 27, 2015 | SVP | 1,125 | $129.74 | Sell | $145,957.50 | |
| April 27, 2015 | Director | 68,125 | $129.11 | Sell | $8,795,618.75 | |
| April 22, 2015 | Director | 11,700 | $132.46 | Sell | $1,549,782.00 | |
| April 15, 2015 | Director | 11,700 | $129.25 | Sell | $1,512,225.00 | |
| April 13, 2015 | SVP | 1,125 | $128.60 | Sell | $144,675.00 | |
| April 8, 2015 | Director | 11,700 | $123.26 | Sell | $1,442,142.00 | |
| April 6, 2015 | Director | 12,500 | $118.36 | Sell | $1,479,500.00 | |
| April 2, 2015 | CMO | 2,291 | $115.50 | Sell | $264,610.50 | |
| April 1, 2015 | Director | 11,700 | $115.87 | Sell | $1,355,679.00 | |
| March 25, 2015 | Director | 11,700 | $120.76 | Sell | $1,412,892.00 | |
| March 23, 2015 | SVP | 2,250 | $125.65 | Sell | $282,712.50 | |
| March 23, 2015 | EVP | 17,083 | $132.28 | Sell | $2,259,739.24 | |
| March 23, 2015 | CFO | 6,042 | $125.67 | Sell | $759,298.14 | |
| March 18, 2015 | EVP | 12,000 | $130.00 | Sell | $1,560,000.00 | |
| Feb. 5, 2015 | SVP | 1,688 | $109.75 | Sell | $185,258.00 | |
| Feb. 4, 2015 | Director | 5,700 | $108.81 | Sell | $620,217.00 | |
| Feb. 3, 2015 | SVP | 2,063 | $108.89 | Sell | $224,640.07 | |
| Feb. 2, 2015 | CMO | 1,188 | $109.60 | Sell | $130,204.80 | |
| Jan. 28, 2015 | Director | 10,688 | $122.78 | Sell | $1,312,272.64 | |
| Jan. 26, 2015 | SVP | 1,125 | $125.62 | Sell | $141,322.50 | |
| Jan. 21, 2015 | Director | 10,500 | $125.08 | Sell | $1,313,340.00 | |
| Jan. 14, 2015 | Director | 10,500 | $120.16 | Sell | $1,261,680.00 | |
| Jan. 9, 2015 | Director | 9,861 | $125.04 | Sell | $1,233,019.44 | |
| Jan. 9, 2015 | EVP | 12,000 | $125.00 | Sell | $1,500,000.00 | |
| Jan. 7, 2015 | Director | 10,500 | $119.32 | Sell | $1,252,860.00 | |
| Jan. 2, 2015 | CMO | 2,291 | $122.54 | Sell | $280,739.14 | |
| Dec. 22, 2014 | Director | 10,500 | $117.65 | Sell | $1,235,325.00 | |
| Dec. 17, 2014 | Director | 10,500 | $110.66 | Sell | $1,161,930.00 | |
| Dec. 15, 2014 | CEO | 50,017 | $114.97 | Sell | $5,750,454.49 | |
| Dec. 12, 2014 | SVP | 2,813 | $120.08 | Sell | $337,785.04 | |
| Nov. 28, 2014 | SVP | 8,164 | $119.85 | Sell | $978,455.40 | |
| Nov. 28, 2014 | EVP | 12,000 | $120.00 | Sell | $1,440,000.00 | |
| Nov. 28, 2014 | Director | 10,000 | $120.03 | Sell | $1,200,300.00 | |
| Nov. 26, 2014 | Director | 10,500 | $114.54 | Sell | $1,202,670.00 | |
| Nov. 6, 2014 | Director | 9,900 | $115.21 | Sell | $1,140,579.00 | |
| Nov. 5, 2014 | Director | 30,100 | $112.62 | Sell | $3,389,862.00 | |
| Nov. 3, 2014 | Director | 127,411 | $112.20 | Sell | $14,295,514.20 | |
| Oct. 29, 2014 | Director | 10,500 | $109.44 | Sell | $1,149,120.00 | |
| Oct. 28, 2014 | Director | 2,000 | $114.75 | Sell | $229,500.00 | |
| Oct. 28, 2014 | EVP | 12,000 | $115.00 | Sell | $1,380,000.00 | |
| Oct. 28, 2014 | CMO | 3,438 | $115.00 | Sell | $395,370.00 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Amit Sachdev, Jeffrey M Leiden, Michael Parini, David Altshuler, Jeffrey Chodakewitz, Joshua S. Boger, Yuchun Lee, Ourania Tatsis, Reshma Kewalramani, Sangeeta N Bhatia, Ian F Smith, Bruce I Sachs, Bastiano Sanna, Joshua Boger, Peter Mueller, Carmen Bozic, Charles F Wagner Jr, Margaret G Mcglynn, Kristen Ambrose, Elaine Ullian, Bruce Sachs, Stuart A. Arbuckle, Jonathan Biller, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Jeffrey Leiden, Edward Morrow Atkinson III, Wayne Joseph Riley, Thomas Graney, Mark E Bunnage, Paul Silva, Christiana Stamoulis, Lloyd Carney, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, Kenneth Horton, Paul M. Silva, Ian F. Smith, William D Young, Duncan Mckechnie, and Sangeeta N. Bhatia
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 13, 2026.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.